MD Magazine (11/19, Lutz) reports the anti-seizure medication ezogabine appeared to reduce “the symptoms of major depressive disorder (MDD)” in an 18-patient study, the findings of which were published online Nov. 1 in Molecular Psychiatry. According to MD Magazine, “because of this research, the team was” awarded a grant from the National Institutes of Health “to continue” its work. (SOURCE: APA Headlines)